about the author

Josh Sullivan

josh@endpointsnews.com

author articles

CD­MO AM­RI re­brands and snags a pair of small­er com­pa­nies to aid its shift to be­come a glob­al brand name

4 years ago
R&D
Manufacturing

Gen­er­a­tion Bio snaps up Boston area plant as it rolls out a man­u­fac­tur­ing process it thinks will be a game chang­er

4 years ago
R&D
Manufacturing

Catal­ent lands 2 new part­ner­ships, in­clud­ing for glioblas­toma drug; US drops $153M in­to pan­dem­ic pre­pared­ness

4 years ago
Outsourcing
Manufacturing

As its next big bet, Sana inks long-term lease for man­u­fac­tur­ing site for next-gen cell ther­a­pies

4 years ago
Cell/Gene Tx
Manufacturing

Al­ready sit­ting on a ma­jor stem cell bank, Gen­er­ate looks to grow its re­gen­er­a­tive med­i­cines busi­ness

4 years ago
Outsourcing
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: FDA frees up more Emer­gent vac­cine dos­es; Pfiz­er and Viet­nam dis­cuss tech trans­fer ...

4 years ago
Coronavirus
Manufacturing

A cou­ple months af­ter land­ing $100 mil­lion in fund­ing, Cel­lares grabs part­ner for its Cell Shut­tle

4 years ago
Outsourcing
Manufacturing

Astel­las signs on pluripo­tent stem cell part­ners at Ex­CellThera; Lit­tle Uni­cy­cive brings home $25M af­ter float­ing a ...

4 years ago
News Briefing

Covid-19 roundup: Sci­en­tists in­ves­ti­gate po­ten­tial safe­ty changes to J&J and As­traZeneca vac­cines; WTO lists crit­i­cal ...

4 years ago
Coronavirus

Per­cep­tive hits the pric­ing sweet spot on its lat­est SPAC, kick­start­ing the search for next for­ev­er part­ner

4 years ago
Financing

Af­ter ques­tions sur­round­ing fund­ing, Re­i­Thera re­veals high an­ti­body re­sponse for Covid-19 jab in PhII study

4 years ago
Coronavirus

As 5 more biotechs file their IPOs, one Nas­daq of­fi­cial does­n't see mo­men­tum slow­ing down any­time soon

4 years ago
Financing

Astel­las and Seagen's Pad­cev wins full FDA ap­proval, notch­ing ex­pand­ed la­bel in tough-to-crack urothe­lial can­cer

4 years ago
Pharma
FDA+

With TransCode go­ing pub­lic, in­dus­try sur­pass­es $10B IPO mark; Galect­in's in­hibitor shows PhIb suc­cess in can­cer ...

4 years ago
News Briefing

Pelosi threat­ens to slide drug pric­ing re­form in­to Biden's bud­get bill, re­jects in­dus­try push­back that in­no­va­tion ...

4 years ago
Pharma

Of­ten-passed plant in Col­orado has a new own­er, who's al­ready op­er­at­ing near­by

4 years ago
R&D
Manufacturing

Mo­roc­can gov­ern­ment drops $500M in­to new Re­ci­pharm fill-fin­ish plant in big boost for African man­u­fac­tur­ing

4 years ago
Outsourcing
Manufacturing

Re­call re­port: Teva's chemother­a­py drug re­called af­ter in­ves­ti­ga­tors find par­tic­u­lates in­side vials

4 years ago
Manufacturing

Agenus to move Cal­i­for­nia op­er­a­tions to new bio­man­u­fac­tur­ing clus­ter in Va­cav­ille

4 years ago
Manufacturing

FDA hands a warn­ing let­ter to a Lupin sub­sidiary af­ter fail­ing to main­tain clean­li­ness once again

4 years ago
Outsourcing
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: In a push to vac­ci­nate Asia, South Ko­rea ready to make 1B vac­cine avail­able; Mex­i­co's ...

4 years ago
Coronavirus
Manufacturing

BioN­Tech and Takara en­ter li­cense agree­ment for CAR-T; The FDA has freed an­oth­er batch of J&J's Covid-19 vac­cine

4 years ago
Manufacturing

Bridge­Bio adds 3 more in­sti­tu­tions to its ros­ter of col­lab­o­ra­tors; Ex­sci­en­tia lands Gates Foun­da­tion mon­ey for ...

4 years ago
News Briefing

Rep. Porter calls on HHS in­spec­tor gen­er­al to in­ves­ti­gate FDA-Bio­gen ties pri­or to Aduhelm's ap­proval

4 years ago
Pharma
FDA+
First page Previous page 17181920212223 Next page Last page
A service from the Financial Times